Who to call at OS Therapies Incorporated, and when
Fundz watches for the moments OS Therapies Incorporated starts buying, and tells you who to reach.
- An alert the day OS Therapies Incorporated raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OS Therapies Incorporated, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OS Therapies Incorporated. With Fundz connected, it knows.
OS Therapies Incorporated
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
ostherapies.comAI Executive Summary
AI-powered analysis of 8-K filing content
OS Therapies stockholders approved at the October 21, 2025 annual meeting an asset purchase share issuance to Ayala Pharmaceuticals that may equal or exceed 20% of common stock outstanding as of April 9, 2025, along with a charter amendment raising authorized common shares from 50 million to 150 million and an increase in the equity plan reserve. The votes materially increase potential dilution and expand the company's capacity to issue equity.
Key Takeaways
Stockholders approved issuing shares (or warrants for an equal number of shares) to Ayala Pharmaceuticals in connection with an asset purchase, in an amount at or above 20% of common stock outstanding
Stockholders approved increasing authorized common stock from 50 million to 150 million shares, tripling the company's capacity to issue equity.
2 more takeaways
Related Filings (13)
13 more filings from OS Therapies Incorporated in the last 90 days
Filing Overview
What This Means
OS Therapies Incorporated filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.